Literature DB >> 2139141

The adenovirus E4 17-kilodalton protein complexes with the cellular transcription factor E2F, altering its DNA-binding properties and stimulating E1A-independent accumulation of E2 mRNA.

M J Marton1, S B Baim, D A Ornelles, T Shenk.   

Abstract

E2F is a cellular DNA-binding factor. Its binding activity is changed within adenovirus-infected cells so that it binds cooperatively to pairs of properly spaced and oriented E2F recognition sites. In the work described in this report, the conversion to cooperative binding was shown to require the adenovirus E4 17-kilodalton (kDa) polypeptide. Mutant viruses carrying alterations within the E4 17-kDa coding region failed to generate the infection-specific, cooperatively binding form of E2F. It was possible to alter E2F from uninfected cells so that it bound cooperatively by incubation with a partially purified fraction obtained from infected cells. The E4 17-kDa protein copurified with this activity and was also found to be present in a complex containing E2F. Consistent with its ability to alter the binding of E2F to its recognition sites within the E2 promoter, the E4 17-kDa polypeptide contributed to maximal expression of E2 mRNAs in some cell types. Its ability to enhance E2 transcription did not require expression of the E1A transactivator protein. These results are consistent with a model which proposes that the E4 17-kDa polypeptide binds to the cellular E2F factor, altering its binding behavior and thereby enhancing its ability to stimulate transcription.

Mesh:

Substances:

Year:  1990        PMID: 2139141      PMCID: PMC249396     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  55 in total

1.  Induction of transcription factor AP-1 by adenovirus E1A protein and cAMP.

Authors:  U Müller; M P Roberts; D A Engel; W Doerfler; T Shenk
Journal:  Genes Dev       Date:  1989-12       Impact factor: 11.361

Review 2.  Adenovirus E1A protein paradigm viral transactivator.

Authors:  J Flint; T Shenk
Journal:  Annu Rev Genet       Date:  1989       Impact factor: 16.830

Review 3.  Adenovirus promoters and E1A transactivation.

Authors:  A J Berk
Journal:  Annu Rev Genet       Date:  1986       Impact factor: 16.830

4.  Role of an adenovirus E2 promoter binding factor in E1A-mediated coordinate gene control.

Authors:  I Kovesdi; R Reichel; J R Nevins
Journal:  Proc Natl Acad Sci U S A       Date:  1987-04       Impact factor: 11.205

5.  Regulation of adenovirus gene expression in human WI38 cells by an E1B-encoded tumor antigen.

Authors:  E White; B Faha; B Stillman
Journal:  Mol Cell Biol       Date:  1986-11       Impact factor: 4.272

6.  Adenovirus transforming 19-kD T antigen has an enhancer-dependent trans-activation function and relieves enhancer repression mediated by viral and cellular genes.

Authors:  K Yoshida; L Venkatesh; M Kuppuswamy; G Chinnadurai
Journal:  Genes Dev       Date:  1987-09       Impact factor: 11.361

7.  Activation of the adenovirus 2 protein IX promoter by DNA replication in a transient expression assay.

Authors:  L K Venkatesh; G Chinnadurai
Journal:  Nucleic Acids Res       Date:  1987-03-11       Impact factor: 16.971

8.  The adenovirus early region 4 open reading frame 6/7 protein regulates the DNA binding activity of the cellular transcription factor, E2F, through a direct complex.

Authors:  M M Huang; P Hearing
Journal:  Genes Dev       Date:  1989-11       Impact factor: 11.361

9.  Sequence-independent autoregulation of the adenovirus type 5 E1A transcription unit.

Authors:  P Hearing; T Shenk
Journal:  Mol Cell Biol       Date:  1985-11       Impact factor: 4.272

10.  Promoter interaction of the E1A-inducible factor E2F and its potential role in the formation of a multi-component complex.

Authors:  A S Yee; R Reichel; I Kovesdi; J R Nevins
Journal:  EMBO J       Date:  1987-07       Impact factor: 11.598

View more
  81 in total

1.  "Hit-and-run" transformation by adenovirus oncogenes.

Authors:  M Nevels; B Täuber; T Spruss; H Wolf; T Dobner
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

2.  An arginine-faced amphipathic alpha helix is required for adenovirus type 5 e4orf6 protein function.

Authors:  J S Orlando; D A Ornelles
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

3.  E4orf6 variants with separate abilities to augment adenovirus replication and direct nuclear localization of the E1B 55-kilodalton protein.

Authors:  Joseph S Orlando; David A Ornelles
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

4.  An activity associated with human chromosome 21 permits nuclear colocalization of the adenovirus E1B-55K and E4orf6 proteins and promotes viral late gene expression.

Authors:  Amy M Chastain-Moore; Terry Roberts; Deborah A Trott; Robert F Newbold; David A Ornelles
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

5.  Adenovirus E4orf4 protein reduces phosphorylation of c-Fos and E1A proteins while simultaneously reducing the level of AP-1.

Authors:  U Müller; T Kleinberger; T Shenk
Journal:  J Virol       Date:  1992-10       Impact factor: 5.103

6.  Promoter-specific trans-activation by the adenovirus E1A12S product involves separate E1A domains.

Authors:  V B Kraus; E Moran; J R Nevins
Journal:  Mol Cell Biol       Date:  1992-10       Impact factor: 4.272

7.  Defective synthesis of early region 4 mRNAs during abortive adenovirus infections in monkey cells.

Authors:  D Ross; E Ziff
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

8.  Diverse roles for E4orf3 at late times of infection revealed in an E1B 55-kilodalton protein mutant background.

Authors:  Robin N Shepard; David A Ornelles
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

9.  The downstream regulatory sequence of the adenovirus type 2 major late promoter is functionally redundant.

Authors:  X C Li; W L Huang; S J Flint
Journal:  J Virol       Date:  1992-09       Impact factor: 5.103

10.  Identification of a novel downstream binding protein implicated in late-phase-specific activation of the adenovirus major late promotor.

Authors:  G Mondesert; C Tribouley; C Kedinger
Journal:  Nucleic Acids Res       Date:  1992-08-11       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.